Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease | Gaafar Ragab

Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease

Citation:: Vitale, A., V. Caggiano, P. P. Sfikakis, L. Dagna, G. Lopalco, G. Ragab, F. La Torre, I. A. Almaghlouth, M. C. Maggio, and J. Sota, "Efficacy of canakinumab in patients with still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for still’s disease", Frontiers in Medicine, vol. 10: Frontiers Media SA, pp. 1256243, 2023.

Abstract:

n/a

Notes:

n/a